We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
+$31.2M
Cap. Flow
+$169M
Cap. Flow %
8.75%
Top 10 Hldgs %
45.68%
Holding
151
New
31
Increased
40
Reduced
42
Closed
31

Top Buys

Rank Stock Value
1
ENSG icon
The Ensign Group
ENSG
+$104M
2
EHC icon
Encompass Health
EHC
+$86.2M
3
CTRE icon
CareTrust REIT
CTRE
+$42.1M
4
UNH icon
UnitedHealth
UNH
+$19M
5
INSM icon
Insmed
INSM
+$18.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$68.9M
2
NTRA icon
Natera
NTRA
+$44.5M
3
DOC icon
Healthpeak Properties
DOC
+$32.5M
4
AVTR icon
Avantor
AVTR
+$23.3M
5
QGEN icon
Qiagen
QGEN
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 89.53%
2 Real Estate 5.59%
3 Miscellaneous 4.84%
4 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARS icon
76
Tarsus Pharmaceuticals
TARS
$3.98B
$3.51M 0.18%
+55,710
New +$3.56M
ANRO icon
77
Alto Neuroscience
ANRO
$1.4B
$3.39M 0.18%
128,286
+3,118
+2% +$72.1K
SPRY icon
78
ARS Pharmaceuticals
SPRY
$559M
$3.02M 0.16%
377,007
+240,772
+177% +$2.07M
IFRX icon
79
InflaRx
IFRX
$327M
$2.92M 0.15%
1,304,069
-454,504
-26% -$854K
ISRG icon
80
Intuitive Surgical
ISRG
$130B
$2.88M 0.15%
7,241
-3,878
-35% -$1.69M
ALEC icon
81
Alector
ALEC
$275M
$2.86M 0.15%
1,423,873
+72,767
+5% +$156K
UHS icon
82
PUT
Universal Health Services
UHS
$10B
$2.8M 0.15%
18,800
+600
+3% +$97.5K
VOR icon
83
Vor Biopharma
VOR
$1.48B
$2.76M 0.14%
+149,681
New +$2.26M
DSGN icon
84
Design Therapeutics
DSGN
$947M
$2.75M 0.14%
+190,000
New +$2.37M
KPTI icon
85
Karyopharm Therapeutics
KPTI
$40.6M
$2.7M 0.14%
276,174
– –
QGEN icon
86
CALL
Qiagen
QGEN
$8.98B
$2.66M 0.14%
68,100
-408,200
-86% -$15.2M
PMVP icon
87
PMV Pharmaceuticals
PMVP
$69M
$2.53M 0.13%
1,890,904
-457,456
-19% -$587K
CTNM
88
Contineum Therapeutics
CTNM
$628M
$2.43M 0.13%
148,017
+1,606
+1% +$21.1K
EVMN
89
Evommune Inc
EVMN
$445M
$2.32M 0.12%
174,460
+119,780
+219% +$2.78M
AMRN
90
Amarin Corp
AMRN
$288M
$2.32M 0.12%
145,296
-2,419
-2% -$35.7K
SPRB
91
Spruce Biosciences
SPRB
$166M
$2.16M 0.11%
+40,000
New +$2.24M
RGEN icon
92
Repligen
RGEN
$9.46B
$1.96M 0.1%
14,401
-106,384
-88% -$13.1M
IVVD icon
93
Invivyd
IVVD
$243M
$1.95M 0.1%
2,237,015
-39,334
-2% -$49.3K
PRQR icon
94
ProQR Therapeutics
PRQR
$292M
$1.9M 0.1%
+1,022,265
New +$1.68M
GRCE
95
Grace Therapeutics
GRCE
$44.2M
$1.75M 0.09%
772,900
+16,300
+2% +$45.1K
AVR
96
Anteris Technologies
AVR
$881M
$1.64M 0.08%
166,229
-234,958
-59% -$1.79M
VIR icon
97
Vir Biotechnology
VIR
$1.93B
$1.6M 0.08%
156,636
-93,364
-37% -$888K
EDIT icon
98
Editas Medicine
EDIT
$496M
$1.49M 0.08%
458,809
+167,890
+58% +$491K
WHWK
99
Whitehawk Therapeutics
WHWK
$262M
$1.39M 0.07%
303,306
-3,494
-1% -$14.5K
TECH icon
100
Bio-Techne
TECH
$11.4B
$1.36M 0.07%
19,308
-106,588
-85% -$5.76M
2 3
4
5 6

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Eversept Partners held 151 positions worth $1.93B, up 1.6% from $1.9B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Eversept Partners deployed $169M of net new capital in Q2 2026, opening 31 new positions and adding to 40 existing holdings. Its largest new stake was CareTrust REIT: 1,072,015 shares worth $43.3M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 74% a quarter earlier, followed by Real Estate and Miscellaneous.

On the sell side, the largest reduction was GSK, an estimated $68.9M trimmed.

  • Eversept Partners's largest Q2 2026 buy was CareTrust REIT: 1,072,015 shares worth $43.3M.
  • Eversept Partners added most to The Ensign Group in Q2 2026, an estimated $104M increase.
  • Eversept Partners's biggest Q2 2026 reduction was GSK, cutting an estimated $68.9M.
  • Eversept Partners fully exited Healthpeak Properties in Q2 2026, selling an estimated $32.5M.
  • Eversept Partners's ten largest holdings make up 46% of its $1.93B portfolio in Q2 2026.
  • Eversept Partners opened 31 new positions and closed 31 in Q2 2026.
  • Eversept Partners's portfolio value rose 1.6% quarter-over-quarter to $1.93B.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.